PIOGLITAZONE VERSUS VITAMIN E VERSUS PLACEBO FOR THE TREATMENT OF NONDIABETIC
PIOGLITAZONE VERSUS VITAMIN E VERSUS PLACEBO FOR THE TREATMENT OF NONDIABETIC
批准号:
7608216
负责人:
Arthur McCullough
金额:
$0.59万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2007-09-16
关键词:
Alcohol consumptionAlcoholic HepatitisClinicalComputer Retrieval of Information on Scientific Projects DatabaseConditionDiseaseFundingGrantHistologyInstitutionLiverLiver CirrhosisMicroscopeObesityOutcomePatient observationPioglitazonePlacebosResearchResearch PersonnelResourcesSourceTissuesUnited States National Institutes of HealthVitaminsWomandiabeticnon-diabeticnonalcoholic steatohepatitis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The term "nonalcoholic steatohepatitis "(NASH)" was used to describe the initial observation of patients with conditions produced by a disease found in obese, diabetic women with no extreme alcohol intake. The liver tissue when looked under the microscope, (histology) was similar to alcoholic hepatitis. NASH is a common disease and can have serious clinical outcomes such as liver cirrhosis with its complications that are associated with this liver condition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金